Mycancer

MYLeukaemia is a research project that aims to drive the future of cancer therapy beyond current patient trial-and-error treatments with the design of the next generation of functional ex vivo drug testing powered by cutting-edge Organ-on-Chip technology. With MYLeukaemia Organ-on-Chip platform we expect to advance knowledge on residual disease emergence in distinct leukaemia subtypes; and translate it into the development of new prognostic markers & therapeutic targets for Leukaemia eradication. This entrepreneurship venture originated in an Foundation for Science and Technology (FCT)-funded R&D project and gathers scientific experts in the fields of both clinical and experimental leukaemia, cancer drug resistance, tissue engineering, biomaterials, microfluidics, proteomics & bioinformatics analysis in a cohesive and transdisciplinary approach taking on the challenge to drive functional precision medicine in Leukaemia care. 🧬 This LinkedIn page is a space to share our research and our members’ knowledge with the open community. Keep an eye out for our upcoming posts!